The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer
|
|---|---|
| Published in |
Frontiers in oncology, March 2019
|
| DOI | 10.3389/fonc.2019.00195 |
| Pubmed ID | |
| Authors |
Jose M. Pacheco, D. Ross Camidge, Robert C. Doebele, Erin Schenk |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Switzerland | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 94 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 13% |
| Student > Master | 12 | 13% |
| Student > Ph. D. Student | 11 | 12% |
| Other | 10 | 11% |
| Student > Bachelor | 7 | 7% |
| Other | 14 | 15% |
| Unknown | 28 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 22% |
| Biochemistry, Genetics and Molecular Biology | 15 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 10% |
| Nursing and Health Professions | 4 | 4% |
| Immunology and Microbiology | 4 | 4% |
| Other | 10 | 11% |
| Unknown | 31 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2019.
All research outputs
#16,123,626
of 25,837,817 outputs
Outputs from Frontiers in oncology
#5,106
of 22,773 outputs
Outputs of similar age
#204,685
of 365,884 outputs
Outputs of similar age from Frontiers in oncology
#105
of 273 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,773 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,884 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.